Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD)

Clinical trial NCT00078221 · UNKNOWN

Trial details

NCT number: NCT00078221
Sponsor: OccuLogix
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Degeneration

Start date: 1999-08-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.